- Home
- KALA vs STAI Comparison
KALA vs STAI Comparison
Compare KALA & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- STAI
- Stock Information
- Founded
- KALA 2009
- STAI 2011
- Country
- KALA United States
- STAI United States
- Employees
- KALA N/A
- STAI N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- STAI
- Sector
- KALA Health Care
- STAI
- Exchange
- KALA Nasdaq
- STAI Nasdaq
- Market Cap
- KALA 26.2M
- STAI 24.6M
- IPO Year
- KALA 2017
- STAI N/A
- Fundamental
- Price
- KALA $14.65
- STAI $0.37
- Analyst Decision
- KALA Strong Buy
- STAI
- Analyst Count
- KALA 3
- STAI 0
- Target Price
- KALA $19.00
- STAI N/A
- AVG Volume (30 Days)
- KALA 209.7K
- STAI 6.3M
- Earning Date
- KALA 08-08-2025
- STAI 10-26-2025
- Dividend Yield
- KALA N/A
- STAI N/A
- EPS Growth
- KALA N/A
- STAI N/A
- EPS
- KALA N/A
- STAI N/A
- Revenue
- KALA N/A
- STAI $907,637.00
- Revenue This Year
- KALA N/A
- STAI N/A
- Revenue Next Year
- KALA N/A
- STAI N/A
- P/E Ratio
- KALA N/A
- STAI N/A
- Revenue Growth
- KALA N/A
- STAI N/A
- 52 Week Low
- KALA $2.92
- STAI $0.35
- 52 Week High
- KALA $15.80
- STAI $9.07
- Technical
- Relative Strength Index (RSI)
- KALA 82.92
- STAI 33.26
- Support Level
- KALA $8.50
- STAI $0.42
- Resistance Level
- KALA $15.80
- STAI $0.45
- Average True Range (ATR)
- KALA 1.25
- STAI 0.05
- MACD
- KALA 0.55
- STAI -0.00
- Stochastic Oscillator
- KALA 86.77
- STAI 5.11
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About STAI ScanTech AI Systems Inc. Common stock
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.